{'The cephalosporin breakpoints for Enterobacteriaceae will detect all clinically important resistance mechanisms (including ESBL and plasmid mediated AmpC). Some isolates that produce beta-lactamases are susceptible or intermediate to 3rd or 4th generation cephalosporins with these breakpoints and should be reported as tested, i.e. the presence or absence of an ESBL does not in itself influence the categorisation of susceptibility. ESBL detection and characterisation are recommended for public health and infection control purposes.': [('Enterobacterales', 'Cefaclor'), ('Enterobacterales', 'Cefadroxil'), ('Enterobacterales', 'Cefalexin'), ('Enterobacterales', 'Cefazolin'), ('Enterobacterales', 'Cefepime'), ('Enterobacterales', 'Cefixime'), ('Enterobacterales', 'Cefotaxime'), ('Enterobacterales', 'Cefpodoxime'), ('Enterobacterales', 'Ceftaroline'), ('Enterobacterales', 'Ceftazidime'), ('Enterobacterales', 'Ceftazidime-avibactam'), ('Enterobacterales', 'Ceftibuten'), ('Enterobacterales', 'Ceftobiprole'), ('Enterobacterales', 'Ceftolozane-tazobactam'), ('Enterobacterales', 'Ceftriaxone'), ('Enterobacterales', 'Cefuroxime'), ('Enterobacterales', 'Cefuroxime')], 'The carbapenem breakpoints for Enterobacteriaceae will detect all clinically important resistance mechanisms (including the majority of carbapenemases). Some isolates that produce carbapenemase are categorised as susceptible with these breakpoints and should be reported as tested, i.e. the presence or absence of a carbapenemase does not in itself influence the categorisation of susceptibility. Carbapenemase detection and characterisation are recommended for public health and infection control purposes.': [('Enterobacterales', 'Doripenem'), ('Enterobacterales', 'Ertapenem'), ('Enterobacterales', 'Imipenem'), ('Enterobacterales', 'Meropenem')], 'The aztreonam breakpoints for Enterobacteriaceae will detect clinically important resistance mechanisms (including ESBL). Some isolates that produce beta-lactamases are susceptible or intermediate to aztreonam with these breakpoints and should be reported as tested, i.e. the presence or absence of an ESBL does not in itself influence the categorisation of susceptibility. ESBL detection and characterisation are recommended for public health and infection control purposes.': [('Enterobacterales', 'Aztreonam')], 'Most staphylococci are penicillinase producers, which make them resistant to benzylpenicillin, phenoxymethylpenicillin, ampicillin, amoxicillin, piperacillin and ticarcillin. When staphylococci test as susceptible to benzylpenicillin and cefoxitin they can be reported as susceptible to the above agents. However, the efficacy of oral formulations, particularly phenoxymethylpenicillin, is uncertain. Isolates that test as resistant to benzylpenicillin but susceptible to cefoxitin are susceptible to Î²-lactamase inhibitor combinations, the isoxazolylpenicillins (oxacillin, cloxacillin, dicloxacillin and flucloxacillin), nafcillin and many cephalosporins. With the exception of ceftaroline and ceftobiprole, cefoxitin-resistant isolates are resistant to all beta-lactam agents.': [('Staphylococcus spp.', 'Benzylpenicillin'), ('Staphylococcus spp.', 'Benzylpenicillin'), ('Staphylococcus spp.', 'Benzylpenicillin'), ('Staphylococcus spp.', 'Ampicillin'), ('Staphylococcus spp.', 'Ampicillin-sulbactam'), ('Staphylococcus spp.', 'Ticarcillin'), ('Staphylococcus spp.', 'Ticarcillin-clavulanic acid'), ('Staphylococcus spp.', 'Temocillin'), ('Staphylococcus spp.', 'Phenoxymethylpenicillin'), ('Staphylococcus spp.', 'Phenoxymethylpenicillin'), ('Staphylococcus spp.', 'Oxacillin'), ('Staphylococcus spp.', 'Cloxacillin')], 'Ampicillin susceptible S. saprophyticus are mecA-negative and susceptible to ampicillin, amoxicillin and piperacillin (without or with a beta-lactamase inhibitor).': [('Staphylococcus spp.', 'Ampicillin'), ('Staphylococcus spp.', 'Ampicillin-sulbactam')], 'S. aureus, S. lugdunensis and S. saprophyticus with oxacillin MIC values >2 mg/L are mostly methicillin resistant due to the presence of the mecA or mecC gene. The corresponding oxacillin MIC for coagulase-negative staphylococci other than S. saprophyticus and S. lugdunensis is >0.25 mg/L.': [('Staphylococcus spp.', 'Oxacillin')], 'Susceptibility of staphylococci to cephalosporins is inferred from the cefoxitin susceptibility except for cefixime, ceftazidime, ceftazidime-avibactam, ceftibuten and ceftolozane-tazobactam, which do not have breakpoints and should not be used for staphylococcal infections. Some methicillin-resistant S. aureus are susceptible to ceftaroline and ceftobiprole, see Notes 5/D and 7/F.': [('Staphylococcus spp.', 'Cefaclor'), ('Staphylococcus spp.', 'Cefadroxil'), ('Staphylococcus spp.', 'Cefixime'), ('Staphylococcus spp.', 'Cefotaxime'), ('Staphylococcus spp.', 'Cefoxitin'), ('Staphylococcus spp.', 'Cefoxitin'), ('Staphylococcus spp.', 'Cefpodoxime'), ('Staphylococcus spp.', 'Ceftaroline'), ('Staphylococcus spp.', 'Ceftaroline'), ('Staphylococcus spp.', 'Ceftobiprole'), ('Staphylococcus spp.', 'Ceftolozane-tazobactam')], 'S. aureus and S. lugdunensis with cefoxitin MIC values >4 mg/L and S. saprophyticus with cefoxitin MIC values >8 mg/L are methicillin resistant, mostly due to the presence of the mecA or mecC gene. Disk diffusion reliably predicts methicillin resistance.': [('Staphylococcus spp.', 'Cefoxitin')], 'Methicillin-susceptible isolates can be reported susceptible to ceftaroline without further testing.': [('Staphylococcus spp.', 'Ceftaroline'), ('Staphylococcus spp.', 'Ceftaroline')], 'Methicillin-susceptible isolates can be reported susceptible to ceftobiprole without further testing.': [('Staphylococcus spp.', 'Ceftobiprole')], 'Susceptibility of staphylococci to carbapenems is inferred from the cefoxitin susceptibility.': [('Staphylococcus spp.', 'Doripenem'), ('Staphylococcus spp.', 'Ertapenem')], 'The susceptibility of streptococcus groups A, B, C and G to penicillins is inferred from the benzylpenicillin susceptibility with the exception of phenoxymethylpenicillin and isoxazolylpenicillins for streptococcus group B.': [('Streptococcus groups A, B, C and G', 'Benzylpenicillin'), ('Streptococcus groups A, B, C and G', 'Ampicillin-sulbactam'), ('Streptococcus groups A, B, C and G', 'Amoxicillin-clavulanic acid'), ('Streptococcus groups A, B, C and G', 'Piperacillin'), ('Streptococcus groups A, B, C and G', 'Piperacillin-tazobactam'), ('Streptococcus groups A, B, C and G', 'Ticarcillin')], 'The susceptibility of streptococcus groups A, B, C and G to carbapenems is inferred from the benzylpenicillin susceptibility.': [('Streptococcus groups A, B, C and G', 'Doripenem')], 'Isolates susceptible to tetracycline are also susceptible to doxycycline and minocycline, but some resistant to tetracycline may be susceptible to minocycline and/or doxycycline. An MIC method should be used to test doxycycline susceptibility of tetracycline resistant isolates if required.': [('Streptococcus groups A, B, C and G', 'Doxycycline'), ('Streptococcus groups A, B, C and G', 'Minocycline')], 'Isolates susceptible to linezolid can be reported susceptible to tedizolid.': [('Streptococcus groups A, B, C and G', 'Tedizolid')], 'Susceptibility to ampicillin, amoxicillin, piperacillin and ticarcillin can be inferred from susceptibility to benzylpenicillin.': [('Gram-negative anaerobes', 'Benzylpenicillin'), ('Gram-negative anaerobes', 'Ampicillin'), ('Gram-negative anaerobes', 'Amoxicillin'), ('Gram-negative anaerobes', 'Piperacillin'), ('Gram-negative anaerobes', 'Ticarcillin')], 'Infer susceptibility from ampicillin susceptibility.': [('Aerococcus sanguinicola and urinae', 'Amoxicillin')], 'Susceptibility can be inferred from ciprofloxacin susceptibility.': [('Aerococcus sanguinicola and urinae', 'Levofloxacin')]}